Compare · head to head
Apogee Therapeutics vs Protagonist Therapeutics
Apogee Therapeutics ranks higher overall — 360 rank 58 vs 27.
Apogee Therapeutics leads on Sentiment (66 vs 50). The two are close on Quality, Growth and Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | Small |
| ISIN | US03770N1019 | US74366E1029 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 58 | 27 |
| Value | NR | 39 |
| Quality | 50 | 50 |
| Growth | 57 | 53 |
| Safety | 36 | 33 |
| Sentiment | 66 | 50 |
| Quality details | ||
| Profitability | 49 | 45 |
| Cash Truth | NR | 55 |
Apogee Therapeutics vs Connect Biopharma HoldingsApogee Therapeutics vs Vir BiotechnologyApogee Therapeutics vs ImageneBioAdd a third stock →
Full analyses: Apogee Therapeutics · Protagonist Therapeutics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100